WATSON 837 15 (Clorazepate Dipotassium 15 mg)
Pill with imprint WATSON 837 15 is Pink, U-shape and has been identified as Clorazepate Dipotassium 15 mg. It is supplied by Watson Pharmaceuticals.
Clorazepate is used in the treatment of anxiety; alcohol withdrawal; seizure prevention and belongs to the drug class benzodiazepines. FDA has not classified the drug for risk during pregnancy. Clorazepate 15 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).
Images for WATSON 837 15
Clorazepate Dipotassium
- Imprint
- WATSON 837 15
- Strength
- 15 mg
- Color
- Pink
- Shape
- U-shape
- Availability
- Prescription only
- Drug Class
- Benzodiazepines
- Pregnancy Category
- N - Not classified
- CSA Schedule
- 4 - Some potential for abuse
- Labeler / Supplier
- Watson Pharmaceuticals
- National Drug Code (NDC)
- 52544-0837
More about clorazepate
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 41 Reviews
- Drug class: benzodiazepines
- FDA Alerts (1)
Consumer resources
Other brands: Tranxene, Tranxene T-Tab, Tranxene SD
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
